Scanning Mutagenesis Identifies Amino Acid Side Chains in Transmembrane Domain 5 of the M1Muscarinic Receptor that Participate in Binding the Acetyl Methyl Group of Acetylcholine
- 1 July 2000
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 58 (1) , 175-184
- https://doi.org/10.1124/mol.58.1.175
Abstract
The exofacial part of transmembrane domain 5 (TMD 5) of the cationic amine-binding subclass of 7-transmembrane receptors is thought to be important in binding the side chain of the agonist. Residues Ile-188 through Ala-196 in TMD 5 of the M1 muscarinic acetylcholine receptor (mAChR) have been studied by Cys- and Ala-scanning mutagenesis. The results are consistent with a helical conformation for this sequence. The positively charged sulfhydryl reagentN-trimethyl-2-aminoethyl methanethiosulfonate reacted selectively with Phe-190 → Cys, Thr-192 → Cys, and Ala-193 → Cys, indicating that the face of TMD 5 accessible from the binding site crevice is consistent with a recent model by Baldwin and colleagues of the transmembrane domain of the 7-transmembrane receptors. In contrast, the acetylcholine derivative bromoacetylcholine reacted selectively with Thr-192 → Cys, which forms the focus of a group of amino acids (Ile-188, Thr-189, Thr-192, Ala-196) whose mutation decreased the binding affinity of the transmitter ACh itself. The center of this patch of residues is offset to one side of the binding pocket, suggesting that a rotation of TMD 5, relative to that implied by the Baldwin model, may be necessary to optimize the anchoring of acetylcholine within the binding site of the M1 mAChR. An induced rotation of TMD 5 could contribute to the formation of the activated state of the receptor.Keywords
This publication has 30 references indexed in Scilit:
- Roles of threonine 192 and asparagine 382 in agonist and antagonist interactions with M1 muscarinic receptorsBritish Journal of Pharmacology, 1999
- Binding, gating, affinity and efficacy: The interpretation of structure‐activity relationships for agonists and of the effects of mutating receptorsBritish Journal of Pharmacology, 1998
- Agonists induce conformational changes in transmembrane domains III and VI of the beta 2 adrenoceptorThe EMBO Journal, 1997
- Interaction of Tryptamine and Ergoline Compounds with Threonine 196 in the Ligand Binding Site of the 5-Hydroxytryptamine6 ReceptorMolecular Pharmacology, 1997
- An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors 1 1Edited by R. HuberJournal of Molecular Biology, 1997
- Cysteine scanning mutagenesis of transmembrane domain V of the M1 muscarinic receptorLife Sciences, 1997
- Amino acids of the α1B‐adrenergic receptor involved in agonist binding: differences in docking catecholamines to receptor subtypesFEBS Letters, 1996
- [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptorsPublished by Elsevier ,1995
- The role of conserved aspartate and serine residues in ligand binding and in function of the 5‐HT1A receptor: A site‐directed mutation studyFEBS Letters, 1992
- Bromoacetylcholine as an affinity label of the acetylcholine receptor from Torpedo californicaBiochemical and Biophysical Research Communications, 1978